Featured
Multiple Myeloma Treatment: A Long-Term, Stage-Based Journey
Outbreak Watch Oct 17, 2026
Trial Briefs Oct 16, 2026
Drug Approvals Oct 15, 2026
The FDA approves ropeginterferon alfa-2b-njft for essential thrombocythemia, the first new treatment for the rare...
Breast cancer diagnosis taught Dr. Molly Greenwade, an oncologist, lessons on early detection while juggling...
A study in Nature overturns the assumption that longer sleep is universally better for aging....
Read our latest Drug Approvals articles.
Therapeutic phlebotomy is one of the key treatments for managing polycythemia vera risks, helping lower...
Most breast bruises are not linked to breast cancer unless they persist beyond two weeks,...
Doctors reject federal vaccine changes lacking scientific backing as top medical groups like AAP and...
Stubborn eczema may signal hidden conditions, so the American Academy of Dermatology now urges doctors to run new tests before escalating treatment.
Stubborn eczema may signal hidden conditions, so the American Academy of Dermatology now urges doctors to run new tests before...
The new American Association of Neurology and American Headache Society guideline outlines migraine preventive pharmacologic treatment for adults,.
Early kidney disease diagnosis rates remain stagnant despite increased screening, highlighting challenges in healthcare detection.
Vonoprazan significantly reduces nighttime reflux symptoms in patients with NERD, offering a promising new treatment option for better sleep.
New diagnostic guidelines for suspected epilepsy focus on ruling out seizures and classifying focal or generalized types—experts emphasize patient history...
Zorevunersen dravet patients showed adaptive gains over two years, surpassing standard antiseizure therapy in a study at the Epilepsy Congress.
New study finds valbenazine significantly improves quality of life for adults with tardive dyskinesia.
Discover how dual therapy is reshaping spinal muscular atrophy treatment as experts debate combining treatments to improve SMA patient outcomes.
The American Academy of Neurology and American Headache Society released an updated migraine prevention guideline for adults, replacing the 2012.
Study reveals combined risk factors significantly increase late-onset Parkinson disease risk, with multiple exposures showing synergistic effects beyond individ